Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging

Fig. 5

The effect of low dose bevacizumab treatment on K trans, v e, and ADC. K trans, normalized K trans, v e, and ADC before treatment, and 3 and 7 days after the treatment started, in untreated and bevacizumab treated A-07 (a) and R-18 (b) tumors. Colums, means of 4-7 tumors, bars, SEM. Statistical comparisons of the data were carried out by the Student’s t test or the Mann–Whitney rank sum test. P-values are indicated in the panels where the statistical tests revealed significant or borderline significant differences between untreated and bevacizumab-treated tumors

Back to article page